Publications by authors named "Gerd-Ruediger R Burmester"

Claim this Profile
S
Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease.
Gerd R Burmester, Atul Deodhar, Alan D Irvine, Remo Panaccione, Kevin L Winthrop

Adv Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid Arthritis.
Gerd Burmester, Jakub Trefler, Artur Racewicz, Janusz Jaworski, Agnieszka Zielińska

Clin Drug Investig· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What are the most important quality of life domains for patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria?
Katherine J Taylor, Susanne Singer, Saskia Langemeijer, Richard J Kelly, Louise Arnold, Pascale O Burmester

Ann Hematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel ecological momentary assessment app for the investigation of daily cognitive functioning in breast cancer survivors: a feasibility study.
Annalee L Cobden, Jake Burnett, Jacqueline B Saward, Alex Burmester, Mervyn Singh

Support Care Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of Intravenous Candidate Biosimilar CT-P47 and Reference Tocilizumab: A Randomized, Double-Blind, Phase 1 Study.
Miwa Haranaka, Takashi Eto, Takanori Tanaka, Rie Yazawa, Gerd Burmester

J Clin Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attentional Processing Biases in Young People With Binging and Purging Behavior.
Aglaia Freccero, Victoria Burmester, Rachel Rodrigues, Alessia Gallucci, Dasha Nicholls

Brain Behav· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis, including 8 weeks of switching data from reference tocilizumab to CT-P47.
Josef S Smolen, Jakub Trefler, Artur Racewicz, Janusz Jaworski, Agnieszka Zielińska, Gerd R Burmester

RMD Open· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials.
Gerd R Burmester, Jayne Stigler, Andrea Rubbert-Roth, Yoshiya Tanaka, Valderilio F Azevedo

Rheumatol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update.
Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, Daniel Aletaha, Xenofon Baraliakos, Gerd R Burmester

Ann Rheum Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
Juergen Rech, Koray Tascilar, Melanie Hagen, Arnd Kleyer, Bernhard Manger, Gerd R Burmester

Lancet· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Filgotinib Demonstrates Efficacy in Rheumatoid Arthritis Independent of Smoking Status: Post Hoc Analysis of Phase 3 Trials and Claims-Based Analysis.
Jeffrey R Curtis, Paul Emery, Bryan Downie, Yan Zhong, Jinfeng Liu, Gerd Rüdiger Burmester

Rheumatol Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Upadacitinib in Immune-Mediated Inflammatory Diseases: Systematic Literature Review of Indirect and Direct Treatment Comparisons of Randomized Controlled Trials.
Eduardo Mysler, Gerd R Burmester, Christopher D Saffore, John Liu, Lani Wegrzyn

Adv Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years.
Christina Charles-Schoeman, Jon T Giles, Nancy E Lane, Ernest Choy, Daniel E Furst, Gerd R Burmester

Rheumatol Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What Have We Learned?
Ali Berkant Avci, Eugen Feist, Gerd R Burmester

BioDrugs· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients.
Rieke Alten, Gerd R Burmester, Marco Matucci-Cerinic, Jean-Hugues Salmon, Andrew Östör

Rheumatol Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis.
Gerd R Burmester, Laura C Coates, Stanley B Cohen, Yoshiya Tanaka, Ivana Vranic

Rheumatol Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial.
Eric L Matteson, Martin Aringer, Gerd R Burmester, Heiko Mueller, Lizette Moros

Clin Rheumatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Daniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, Christian Dejaco, Maxime Dougados, Gerd-Rüdiger R Burmester

Ann Rheum Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of hemoglobin levels with radiographic progression in patients with rheumatoid arthritis: an analysis from the BRASS registry.
Nancy Shadick, Owen Hagino, Amy Praestgaard, Stefano Fiore, Michael Weinblatt, Gerd Burmester

Arthritis Res Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive autoantibody profiles in systemic sclerosis: Clinical cluster analysis.
Jakob Höppner, Christoph Tabeling, Vincent Casteleyn, Claudia Kedor, Wolfram Windisch, Gerd Rüdiger Burmester

Front Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA).
Michaela Koehm, Ann C Foldenauer, Tanja Rossmanith, Rieke Alten, Martin Aringer, Gerd R Burmester

J Clin Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases.
Kastriot Kastrati, Daniel Aletaha, Gerd R Burmester, Eva Chwala, Christian Dejaco

RMD Open· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B Cell Numbers Predict Humoral and Cellular Response Upon SARS-CoV-2 Vaccination Among Patients Treated With Rituximab.
Ana-Luisa Stefanski, Hector Rincon-Arevalo, Eva Schrezenmeier, Kirsten Karberg, Franziska Szelinski, Gerd R Burmester

Arthritis Rheumatol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases.
Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Fredrik N Albach, Jens Klotsche, Veronika Scholz, Gerd-Rüdiger Burmester

Ann Rheum Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased replication stress and R-loop accumulation in EGFRvIII-expressing glioblastoma present new therapeutic opportunities.
Nina Struve, Konstantin Hoffer, Anna-Sophie Weik, Britta Riepen, Leonie Krug, Jasmin Burmester

Neurooncol Adv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis